Skip to search formSkip to main contentSkip to account menu

miriplatin

National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Organoplatinum Compounds

Narrower (1)

SM 11355

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Angiographic Evaluation of Vascular Damage in Rat Liver After Administration of Epirubicin or Miriplatin.
BACKGROUND Maintaining the function of blood vessels is important for the control of hepatocellular carcinoma (HCC) during… 
2017
2017
Usefulness and limitations of balloon‐occluded transcatheter arterial chemoembolization using miriplatin for patients with four or fewer hepatocellular carcinoma nodules
The aim of this study is to clarify the usefulness and limitations of balloon‐occluded transcatheter arterial chemoembolization… 
2017
2017
Feasibility and Safety of Repeated Transarterial Chemoembolization Using Miriplatin-Lipiodol Suspension for Hepatocellular Carcinoma.
AIM To retrospectively evaluate the feasibility and safety of repeated transarterial chemoembolization (TACE) three or more times… 
2016
2016
Clinical utility of radiofrequency ablation following transarterial injection of miriplatin-iodized oil suspension in small hepatocellular carcinoma
PurposeTo retrospectively evaluate the clinical utility of radiofrequency ablation (RFA) following transarterial injection of… 
2014
2014
Transcatheter arterial chemoembolization for hepatocellular carcinoma: Comparison of the therapeutic efficacies between miriplatin and epirubicin
The therapeutic efficacy of transcatheter arterial chemoembolization (TACE) using miriplatin was evaluated in comparison with… 
2013
2013
Comparison of epirubicin hydrochloride and miriplatin hydrate as anticancer agents for transcatheter arterial chemoembolization of hepatocellular carcinoma
The aim of this retrospective study was to compare the local control effects of transcatheter arterial chemoembolization (TACE… 
2013
2013
Selective accumulation of platinum and formation of platinum–DNA adducts in hepatocellular carcinoma after transarterial chemoembolization with miriplatin
Miriplatin, a lipophilic platinum complex, is a novel intra‐arterial chemotherapeutic agent for hepatocellular carcinoma (HCC… 
2012
2012
A transcatheter arterial chemotherapy using a novel lipophilic platinum derivative (miriplatin) for patients with small and multiple hepatocellular carcinomas
Background/purpose Miriplatin is a platinum complex developed to treat hepatocellular carcinoma (HCC) through administration into… 
2011
2011
Development of Miriplatin, a Novel Antitumor Platinum for Hepatocellular Carcinoma
More than 90% of hepatocellular carcinoma (HCC) cases develop from virus-associated chronic hepatitis and cirrhosis, and such… 
2010
2010
Acquired resistance to miriplatin in rat hepatoma AH109A/MP10 is associated with increased Bcl-2 expression, leading to defects in inducing apoptosis.
Miriplatin, a novel lipophilic platinum complex approved to treat hepatocellular carcinoma, is administered into the hepatic… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)